Literature DB >> 2792911

Pelvic exenteration: factors associated with major surgical morbidity.

J T Soper1, A Berchuck, W T Creasman, D L Clarke-Pearson.   

Abstract

Sixty-nine women underwent pelvic exenteration at Duke University Medical Center from 1970 through 1987. The operative mortality rate was 7.2% with a trend toward a reduction during the course of the study. One or more serious gastrointestinal or genitourinary surgical complication occurred in 26 (38%) patients and 20 (29%) required reoperation for these complications. There was a trend (P less than 0.1) toward an increase in surgical complications among patients who received prior radiation therapy and those requiring urinary diversion, with a decrease among those who underwent gracilis flap pelvic reconstruction. Patients with sigmoid or ileal conduits had a significantly higher incidence of severe surgical complications than those with transverse colon conduits or posterior exenteration alone (P less than 0.05). Those in whom an ileal conduit was constructed without gracilis flap pelvic reconstruction had significantly more surgical morbidity compared to those who underwent pelvic reconstruction or received a transverse colon conduit (P less than 0.05). Multiple changes in technique since 1978 including (1) the routine use of surgical staplers for bowel resection and anastomosis, (2) the introduction of the transverse colon conduit, and (3) the use of gracilis flap for pelvic reconstruction have combined to produce a significant (P less than 0.05) decrease in life-threatening surgical complications.

Entities:  

Mesh:

Year:  1989        PMID: 2792911     DOI: 10.1016/0090-8258(89)90020-6

Source DB:  PubMed          Journal:  Gynecol Oncol        ISSN: 0090-8258            Impact factor:   5.482


  8 in total

1.  Comparison of the complications in vertical rectus abdominis musculocutaneous flap with non-reconstructed cases after pelvic exenteration.

Authors:  Heechang Jeon; Eul Sik Yoon; Hi-Jin You; Hyon-Surk Kim; Byung-Il Lee; Seung Ha Park
Journal:  Arch Plast Surg       Date:  2014-11-03

2.  Pelvic exenteration for recurrent or persistent cervical cancer: experience of five years at the National Cancer Institute in Mexico.

Authors:  M A Terán-Porcayo; I Zeichner-Gancz; R A C Gomez del-Castillo; A Beltrán-Ortega; G Solorza-Luna
Journal:  Med Oncol       Date:  2006       Impact factor: 3.064

3.  The effect of body mass index on surgical outcomes and survival following pelvic exenteration.

Authors:  David A Iglesias; Shannon N Westin; Vijayashri Rallapalli; Marilyn Huang; Bryan Fellman; Diana Urbauer; Michael Frumovitz; Pedro T Ramirez; Pamela T Soliman
Journal:  Gynecol Oncol       Date:  2012-01-16       Impact factor: 5.482

4.  Hospital surgical volume and perioperative mortality of pelvic exenteration for gynecologic malignancies.

Authors:  Koji Matsuo; Shinya Matsuzaki; Rachel S Mandelbaum; Kazuhide Matsushima; Maximilian Klar; Brendan H Grubbs; Lynda D Roman; Jason D Wright
Journal:  J Surg Oncol       Date:  2019-11-19       Impact factor: 3.454

Review 5.  The role of palliative surgery in gynecologic cancer cases.

Authors:  Joanie Mayer Hope; Bhavana Pothuri
Journal:  Oncologist       Date:  2013-01-08

6.  Laparoscopic salvage total pelvic exenteration: Is it possible post-chemo-radiotherapy?

Authors:  H Patel; J V Joseph; A Amodeo; K Kothari
Journal:  J Minim Access Surg       Date:  2009-10       Impact factor: 1.407

7.  Retrospective review of pelvic malignancies undergoing total pelvic exenteration.

Authors:  Maureen P Kuhrt; Ravi J Chokshi; David Arrese; Edward W Martin
Journal:  World J Surg Oncol       Date:  2012-06-15       Impact factor: 2.754

8.  Resurrection of the rectus abdominis musculoperitoneal flap for pelvic exenteration?

Authors:  Michael Höckel
Journal:  Gynecol Oncol Rep       Date:  2017-07-12
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.